Skip to main content
Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
41.99
+2.60 (6.60%)
At close: Apr 28, 2026, 4:00 PM EDT
42.49
+0.50 (1.19%)
After-hours: Apr 28, 2026, 4:21 PM EDT

Axogen Revenue

Axogen had revenue of $61.46M in the quarter ending March 31, 2026, with 26.56% growth. This brings the company's revenue in the last twelve months to $238.11M, up 22.41% year-over-year. In the year 2025, Axogen had annual revenue of $225.21M with 20.21% growth.

Revenue (ttm)
$238.11M
Revenue Growth
+22.41%
P/S Ratio
9.20
Revenue / Employee
$382,805
Employees
622
Market Cap
2.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025225.21M37.87M20.21%
Dec 31, 2024187.34M28.33M17.81%
Dec 31, 2023159.01M20.43M14.74%
Dec 31, 2022138.58M11.23M8.81%
Dec 31, 2021127.36M15.06M13.41%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.24B
Enovis 2.25B
Integer Holdings 1.85B
Haemonetics 1.32B
Inspire Medical Systems 911.98M
Neogen 870.56M
Alphatec Holdings 764.16M
NovoCure 655.35M
Revenue Rankings

AXGN News

More News